5-HT3 receptor antagonists
US9346829B2 · kind B2 · utility
4Cited by
7References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 2015 |
| Grant date | May 24, 2016 |
| Priority date | — |
| Expiry date | Mar 12, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of treating nicotine addiction comprising administering a 5-HT3 receptor antagonists of Formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.